Trials / Unknown
UnknownNCT03388073
Evaluation of Plant-based Nutritional Products on Stem Cells
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Natural Immune Systems Inc · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design.
Detailed description
The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design. The research involves testing of acute effects of single doses of antioxidant-rich berry-based extracts, compared to a placebo. Blood samples are taken at baseline and 1 and 2 hours after consuming a single dose. The blood will be used to measure the numbers of different types of stem cells, to evaluate potential effects of stem cell mobilization and homing after consuming plant-based extracts. Adult stem cells are a type of cells that play a role in repairing and rejuvenating various tissue and organs in the body. At NIS Labs, we have shown that many types of plant-based nutritional products have small but reproducible and significant effects on stem cells, cytokines, and regenerative growth factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Berry extract I | Seabuckthorn berry proanthocyanidin extract 250 mg single dose |
| OTHER | Berry Extract II | Seabuckthorn berry proanthocyanidin extract 500 mg single dose |
| OTHER | Berry extract blend | Seabuckthorn berry blend with other berry-based antioxidants |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2018-01-30
- Primary completion
- 2019-12-20
- Completion
- 2020-02-02
- First posted
- 2018-01-02
- Last updated
- 2019-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03388073. Inclusion in this directory is not an endorsement.